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The adult form of myotonic dystrophy type 1 (DM1) presents with paradoxical inconsistencies between severity of brain damage,
relative preservation of cognition, and failure in everyday life. This study, based on the assessment of brain connectivity and
mechanisms of plasticity, aimed at reconciling these conflicting issues. Resting-state functionalMRI and graph theoretical methods
of analysis were used to assess brain topological features in a large cohort of patients with DM1. Patients, compared to controls,
revealed reduced connectivity in a large frontoparietal network that correlated with their isolated impairment in visuospatial
reasoning. Despite a global preservation of the topological properties, peculiar patterns of frontal disconnection and increased
parietal-cerebellar connectivity were also identified in patients’ brains.The balance between loss of connectivity and compensatory
mechanisms in different brain networks might explain the paradoxical mismatch between structural brain damage and minimal
cognitive deficits observed in these patients. This study provides a comprehensive assessment of brain abnormalities that fit well
with both motor and nonmotor clinical features experienced by patients in their everyday life. The current findings suggest that
measures of functional connectivity may offer the possibility of characterizing individual patients with the potential to become a
clinical tool.
1. Introduction
Myotonic dystrophy type 1 (DM1) is the most common
muscular dystrophy observed in adults [1]. It is caused by a
CTG triplet repeat expansion within the myotonic dystro-
phy protein kinase (DMPK) gene located on chromosome
19q13.3, whose inheritance is autosomal dominant [2]. DM1
is a multisystemic disorder dominated by muscular impair-
ment but involving also other organs including the brain
[1].
It is becoming increasingly clearer that most of the
impairment observed in patients with DM1 is driven by
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higher-level dysfunctions [3–7]. DM1 brains have been
demonstrated to be structurally damaged in both tissues, the
grey (GM) and white matter (WM) [7–11], with a specific
anatomical distribution of abnormalities. This structural
damage has been consistently reported across independent
studies [7–11], and it was more recently associated with CTG
triplet expansions in theDMPK gene andmeasures of clinical
severity [7]. Abnormal patterns of brain connectivity have
also been reported in DM1 patients and have been demon-
strated to account for patients’ personality traits [6]. While
mental retardation is frequently observed in the congenital
form of DM1 [12] the adult forms are typically characterized
by isolated cognitive deficits [7, 13].This relative preservation
of global cognition contrasts with the pathological and
neuroimaging evidence of diffuse WM abnormalities [7–
10] and with the paradoxical failure of these patients in
everyday life. In addition, upon investigating functional con-
nectivity within the so-called default mode network, whose
disruption is typically associated with cognitive impairment
in degenerative dementia [14, 15], DM1 patients reveal an
increase of connectivity in some critical nodes [6]. These
data, taken altogether, suggest DM1 as neurodevelopmental
disorder that associates with peculiar rearrangements in
neuronal networks’ segregation and integration properties.
These complex alterations, which are hardly detectable by
structural brain assessments, are likely to account for the
distinctive motor and nonmotor features observed in DM1.
Resting-state functional MRI (RS-fMRI) [16] is one of the
most widely used methods to investigate brain connectivity
in neurological and psychiatric diseases [17, 18], with the
advantage of not requiring participants to perform any active
task. RS-fMRI data can be analysed using different method-
ological approaches. One promising technique is based on
the whole brain analysis driven by graph theory [19], a
mathematical approach that describes complex systems as
networks [20]. In simple words, the brain is conceptualized as
a number of regions (nodes) that are functionally connected
to each other by edges and whose importance and efficiency
within the whole network are determined by their functional
specialization (i.e., segregation) and integration. In this view,
some nodes are more critical (i.e., centrality) for information
processing (efficiency in information transferring) and are
called “hubs.” Abnormal connectivity between “hubs” is
believed to cause more deficits than that between peripheral
nodes [19, 20]. With these concepts in mind, the current
work aimed at assessing topological properties ofDM1 brains,
their potential relationship with genetics, and their ability
in accounting for patients’ motor and nonmotor clinical
features. To the best of our knowledge, this is the first attempt
to investigate brain connectomics in DM1 patients.
2. Materials and Methods
2.1. Participants. Thirty-one patients with a molecular diag-
nosis of DM1 were recruited from the Neuromuscular and
Neurological Rare Diseases Center at San Camillo Forlanini
Hospital (Rome, Italy) and the Institute of Neurology at
the Catholic University of Rome (Rome, Italy). Data from
Table 1: Principal demographic characteristics of studied subjects.
DM1
patients
𝑁 = 31
HS
𝑁 = 26
𝑝 value
Mean (SD) age [years] 39.9 (11.4) 45.7 (13.2) n.s.a
Gender (F/M) 16.0/15.0 19.0/7.0 n.s.b
Mean (SD) years of
formal education 12.4 (2.2) 14.0 (3.3) n.s.
a
aOne-way ANOVA. bChi-square.
DM1 = myotonic dystrophy type 1; HS = healthy subjects.
Table 2: Principal genetic and clinical characteristics of DM1
patients.
DM1
patients
𝑁 = 31
Age at onset:
Childhood-onset (age range: 6–16 years) 12 (38.7%)
Adulthood-onset (age range: 18–60 years) 19 (61.2%)
Size of CTG triplets’ expansion on DMPK gene:
Mean (SD) [range]
637.1
(456.4)
[54–2000]
IDMC nomenclature:
E1 (CTG range: 50–150) (𝑁 and %) 1 (3.0%)
E2 (CTG range: 151–500) (𝑁 and %) 15 (48.4%)
E3 (CTG range: 501–1000) (𝑁 and %) 12(38.74%)
E4 (CTG range: > 1000) (𝑁 and %) 3 (9.7%)
MIRS stage:
Stage 1 (𝑁 and %) 3 (9.7%)
Stage 2 (𝑁 and %) 13 (41.9%)
Stage 3 (𝑁 and %) 11 (35.5%)
Stage 4 (𝑁 and %) 4 (12.8%)
DM1 = myotonic dystrophy type 1; DMPK = myotonic dystrophy protein
kinase; IDMC = international myotonic dystrophy consortium; and MIRS =
muscular impairment rating scale.
part of this patients’ cohort were previously presented in an
independent study [6]. Twenty-six healthy participants were
recruited from Santa Lucia Foundation in Rome (Italy). As
detailed below, CTG expansion size within the DMPK gene
was assessed for DM1 participants and used to classify them
according to the International Myotonic Dystrophy Consor-
tium nomenclature [22]. Demographic characteristics of the
participants are summarized in Table 1. Principal genetic
and clinical characteristics of DM1 patients are summarized
in Table 2. All participants were right-handed as assessed
by the Edinburgh Handedness Inventory [23]. All subjects
underwent clinical assessment to exclude the presence of
major systemic and neurological illnesses in controls and
pathologies different from known comorbidities in DM1
patients. The study was approved by the Ethical Committee
of Santa Lucia Foundation and written informed consent
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was obtained from all participants before study initiation. All
procedures performed in this study were in accordance with
the 1964 Helsinki declaration and its later amendments or
comparable ethical standards.
2.2. Genetic Assessment. Normal and protomutated alleles
were analysed using “touchdown” PCR on DNA obtained
from peripheral blood leukocytes (PBL). Briefly, 50 pg of
PBL-DNA was amplified in a 20𝜇L volume with fluorescent
labelled primer 101 and primer 102. Reactions were cycled
through eight rounds at 94∘C (30󸀠󸀠), 68∘C (30󸀠󸀠) (−1∘C per
cycle), and 72∘C (30󸀠󸀠), followed by 30 rounds at 94∘C
(30󸀠󸀠), 60∘C (30󸀠󸀠), and 72∘C (30󸀠󸀠). PCR products were
then analysed using an ABI PRISM 310 Genetic Analyzer.
Determination of expanded alleles was performed on 10 pg
of PBL-DNA, which underwent XL-PCR1 and 1% agarose
gel electrophoresis. PCR products were analysed by Southern
blotting with subsequent hybridization to a 32P radiolabeled
(CTG) 7-oligonucleotide probe anddetected using autoradio-
graphy.
2.3. Neuropsychological Assessment. All participants under-
went an extensive neuropsychological battery covering all
cognitive domains, which included (a) Mini Mental State
Examination (MMSE) [24]; (b) Rey’s 15-Word List (Immedi-
ate and 15-min Delayed recall) [25] to assess episodic verbal
memory; (c) Digit Span and Corsi Block Tapping task [26]
forward and backward as measures of short-term memory;
(d) naming objects and verbs subtests of the BADA (“Batteria
per l’Analisi dei Deficit Afasici,” Italian for “Battery for the
analysis of aphasic deficits”) [27] to assess language abilities;
(e) Raven’s Coloured Progressive Matrices [25] to assess
reasoning; (f) copy of simple drawings with and without
landmarks [25] to evaluate constructional abilities; and (g)
Phonological Word Fluency [25] and Stroop test [28] to
explore executive functions. Italian normative data were used
for all tests both for score adjustment (gender, age, and educa-
tion) and for defining normality cut-off scores (95% tolerance
interval). A series of thirteen one-way ANOVAs were used
to test differences in cognitive performance between patients
and controls (𝑝 values < 0.004 after Bonferroni’s correction).
Additionally, in the patient group, MMSE scores were cor-
related with CTG triplet expansion, age of clinical onset,
and Muscular Impairment Rating Scale (MIRS) [29] scores
(𝑝 values < 0.02 after Bonferroni’s correction). Statistical
analyses were performed using SPSS-20 (SPSS Inc., Chicago,
Illinois).
2.4. Image Acquisition and Preprocessing of Resting-State
fMRI. All participants underwent MRI at 3 T, including
(1) 3D Modified Driven Equilibrium Fourier Transform
(MDEFT) scan (TR = 1338ms, TE = 2.4ms, matrix = 256 ×
224, 𝑛. slices = 176, and thickness = 1mm); (2) T2∗ weighted
echo planar imaging (EPI) sensitized to blood oxygenation
level dependent (BOLD) contrast (TR = 2080ms, TE = 30ms,
32 axial slices parallel to AC-PC line, matrix = 64 × 64, pixel
size = 3 × 3mm2, slice thickness = 2.5mm, and flip angle: 70∘)
for resting-state fMRI (RS-fMRI). BOLD EPI images were
collected during rest for 7min and 20 s, resulting in a total
of 220 volumes. During this acquisition, participants were
instructed to keep their eyes closed, not to think of anything
in particular, and not to fall asleep. EPI images were pre-
processed for resting-state fMRI using Statistical Parametric
Mapping 8 (SPM8 http://www.fil.ion.ucl.ac.uk/spm/) and in-
house MATLAB scripts.
The first 4 volumes of each fMRI time series were
discarded to allow for T1 equilibration effects; then, images
underwent headmotion correction (using the standard SPM8
realignment algorithm), compensation for slice-dependent
time shifts, and coregistration to the corresponding MDEFT.
Each MDEFT-volume was segmented using the standard
SPM8 algorithm and the resulting grey matter images were
used to compute each participant’s total grey matter volume.
Segmentation derived normalization parameters were used
to warp the motion and slice-time corrected EPI images
into Montreal Neurological Institute (MNI) coordinates. In-
house software was used to remove the global temporal drift
using a 3rd-order polynomial fit. Data were then filtered
by regressing out movement vectors, average white matter,
and cerebrospinal fluid signal. EPI images were then filtered
using a phase-insensitive band-pass filter (passband 0.01–
0.08Hz) to reduce effects of low frequency drift and high
frequency physiological noise and then smoothed with an
8mm3 FWHM 3D Gaussian Kernel.
2.5. Construction of Connectivity Matrices. In order to define
brain nodes, for each participant, the whole brain was
parcellated into 116 regions of interests (ROIs) applying an
automated anatomical labelling (AAL) atlas adapted to the
EPI space using linear registration. Each ROI corresponds to
a node of the network, and its mean time course was calcu-
lated as the average of the fMRI time series from all voxels
within the region. Correlationmatrices (i.e., adjacencymatri-
ces) were then obtained calculating the correlation between
all pairs of ROI mean signals. The resulting adjacency
matrices were analysed using 2 complementary approaches:
(1) network-based statistics [30], which compares between
groups the strength of connectivity for each pair of nodes
in the network, thus assessing the presence of subnetwork
altered connectivity in patients and (2) graph theory, which
characterizes the network using special indices describing its
shape and properties, including efficiency and resilience to
attack (Brain Connectivity Toolbox) [19].
2.6. Networks-Based Analysis. This analysis was preformed
using the “networks-based statistics” (NBS) tool developed
by Zalesky and coauthors [30] and allowed testing for any
significant difference of inter-Nodal functional connectiv-
ity (in all possible pairwise associations) between DM1
patients and controls. Between-group comparison was based
on a two-sample 𝑡-test, using 50000 permutations and
setting the significant 𝑝 value at 0.005 (NBS-connectome
corrected for multiple comparisons). Nodes with higher
number of connections were considered more crucial for
information processing and defined as “hubs.” According to
previous literature [31], we considered “hubs” those nodes
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whose number of inter-Nodal connections exceeded one
standard deviation the mean number of connections for
every node within the significant network (estimated by
NBS).
Then, using the NBS toolbox, for each DM1 patient,
we extracted the “extent of connectivity” (a measure of
connectivity strength within disrupted networks) to be used
for correlations with clinical/genetic and neuropsychological
variables. For the choice of the most appropriate statisti-
cal approach (parametric versus nonparametric correlation
test), the normality of data distribution was assessed using
the Shapiro-Wilk test (𝑊). MIRS score and CTG triplet
expansion were chosen as clinical/genetic variables in the
correlation analyses with extent of connectivity (Bonferroni’s
correction: 𝛼 = 0.05/2, 𝑝 = 0.025). All neuropsychological
scores were used as cognitive variables for the same corre-
lation analyses (Bonferroni’s correction: 𝛼 = 0.05/13, 𝑝 =
0.004).
2.7. Graph Theory Analysis. A connectivity matrix is a repre-
sentation of a graph, where the nodes correspond to the rows
and columns of the matrix and the edges are characterized
by the values at the intersection of rows and columns. We
used Brain Connectivity Toolbox [19] and MATLAB custom
scripts to explore global and local topological properties
of each participant’s brain. Undirected binary connectivity
matrices were built as thresholding adjacency matrices with
different correlation values for each subject. The reason is
that the choice of a single common threshold across different
subjects leads to comparing networks with different densities,
where density is defined as the ratio between the total number
of edges and the maximum possible number of edges in
the network. In order to prevent spurious differences in
the network topologies due to different density values [32],
multiple correlation thresholds were used for each subject,
obtaining several connectivity matrices for each subject in a
specific density range. In thisway, subjects could be compared
by means of connectivity matrices with the same density
values. The density range was determined checking at each
density value both the absence of isolated nodes and the
presence of small-world properties (i.e., most nodes can be
reached from any other by a small number of steps). In
our case, the lower and the upper limits of this range are,
respectively, 0.19 and 0.47. We chose to use a range step of
0.01 in line with other clinical studies [33, 34].
Details of graph theory and its application to brain
networks can be found in previous papers [19, 20, 35] together
with a full description of all the indices that can be derived
from it. For the purposes of the current investigation, we
focused on the topological measures with a more direct
clinical interpretation [33–38].
As global metrics, mean Clustering Coefficient (i.e., the
fraction of one node’s neighbours that are also neighbours
of each other), Characteristic Path Length (i.e., the average
length of sequences of nodes that form routes), Assortativity
(an index of the likelihood for high-degree nodes to be linked
together), and Modularity (a measure of the presence of a
community structure in a network) were calculated [19]. In
order to further avoid spurious results, Normalized Cluster-
ing Coefficient and path length were also employed.The nor-
malization was performed evaluating the ratio between the
original metrics and those derived from random networks.
Then, the ratio between the normalized mean Clustering
Coefficient and the normalized Characteristic Path Length,
also known as Small-Worldness, was calculated. This index
is associated with both processing high efficiency and low
wiring cost [35]. All global metrics describe brain abilities to
process information in dedicated regions (segregation) and
to coordinate this distributed processing to perform complex
activities (integration).
With respect to local metrics, we considered Betweenness
centrality, Nodal degree, and Nodal efficiency. Betweenness
centrality is defined as the fraction of all the shortest paths
passing through a given node; Nodal degree expresses the
number of connections for each node; Nodal efficiency is
inversely related to each node’s paths length and identifies
the less efficient nodes along certain routes. Higher values
of these topological metrics identify key-nodes for brain
integration and resilience. As explained above, we looked
at a range of densities for each connectivity matrix and
therefore obtained a range for each topological parameter,
each corresponding to a different density value. First, we
examined for each density value the differences between
the two groups. Then, in order to obtain scalar values
for each metric, the area under the curve (AUC) of the
density distribution was calculated. For each considered
global and local measure of connectivity, a two-sample 𝑡-test
was used to assess group differences between DM1 patients
and controls. For further analysis, as an alternative to the
AUC approach, we averaged local and global measures across
densities, to compute the “individual mean values” (Imv-).
These global measures of connectivity (Imv-Clustering Coef-
ficient (Imv-C), the Imv-Normalized Clustering Coefficient
(Imv-NC), the Imv-Characteristic Path Length (Imv-PL),
the Imv-Normalized Characteristic Path Length (Imv-NPL),
the Imv-Small-Worldness (Imv-SWN), the Imv-Modularity
(Imv-M) and the Imv-Assortativity (Imv-A), the Imv-Nodal
degree (Imv-ND), the Imv-Betweenness centrality (Imv-
BC), and the Imv-Nodal efficiency (Imv-NE)) were used
for correlations with patients’ MIRS/CTG triplets expansion
(Bonferroni’s correction: 𝛼 = 0.05/2, 𝑝 = 0.025) and, finally,
with neuropsychological variables (Bonferroni’s correction:
𝛼 = 0.05/13, 𝑝 = 0.004). Moreover, to define an appropriate
statistical analysis, the Shapiro-Wilk test was used again.
3. Results
3.1. Demographic, Clinical, and Neuropsychological Character-
istics. Patients and controls were not significantly different in
age, gender, or years of formal education (F
1,55
= 3.03, chi-
square = 2.75, and F
1,55
= 3.52, resp., all 𝑝 = n.s.) (Table 1).
Table 2 shows the genetic and clinical characteristics of all
recruited patients. As reported in Table 2, most DM1 patients
(19 out of 31, 61.2%) had an adulthood-onset of disease; 12
out of 31 patients (38.7%) had a childhood-onset. Following
the guidelines of the Myotonic Dystrophy Consortium [22],
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Table 3: Performance obtained by DM1 and HS groups on neuropsychological testing.
Domain DM1 patients HS
𝑝 valuea
Test/subtest 𝑁 = 31 𝑁 = 26
Cognitive efficiency
MMSE (normal cut-off ≥ 23.8) 27.9 (1.8) 29.7 (0.6) 0.000
Verbal episodic long-term memory
15-word list:
(i) Immediate recall (cut-off ≥ 28.5) 43.2 (6.0) 44.9 (9.5) n.s.
(ii) Delayed recall (cut-off ≥ 4.6) 9.2 (3.2) 9.8 (2.8) n.s.
Verbal short-term memory
Digit span forward (cut-off ≥ 3.7) 5.3 (2.2) 6.1 (1.3) n.s.
Digit span backward 4.9 (5.1) 5.1 (1.0) n.s.
Visuospatial short-term memory
Corsi span forward (cut-off ≥ 3.5) 5.3 (3.4) 5.5 (0.9) n.s.
Corsi span backward 4.4 (1.5) 5.5 (0.9) n.s.
Language
Naming of objects (cut-off ≥ 22) 27.3 (6.4) 28.9 (1.3) n.s.
Naming of verbs (cut-off ≥ 22) 25.4 (6.1) 26.1 (2.0) n.s.
Reasoning
Raven’s Coloured Progressive Matrices (cut-off ≥ 18.9) 24.6 (8.6) 32.5 (2.6) 0.001
Constructional praxis
Copy of drawings (cut-off ≥ 7.1) 9.9 (5.8) 11.3 (1.2) n.s.
Copy of drawings with landmarks (cut-off ≥ 61.8) 57.4 (19.7) 69.0 (1.8) n.s.
Executive functions
Phonological word fluency (cut-off ≥ 17.3) 30.1 (17.7) 36.0 (8.4) n.s.
Stroop-interference (cut-off ≤ 36.9) 30.2 (15.1) — —
DM1 = myotonic dystrophy type 1; HS = healthy subjects.
For each group of studied subjects, the table shows the performance scores means (SDs) obtained on neuropsychological testing. For each administered test,
appropriate adjustments for gender, age, and education were applied according to the Italian normative data. Available cut-off scores of normality (≥95% of
the lower tolerance limit of the normal population distribution) are also reported for each test. aOne-way ANOVA.
one out of 31 patients (3.0%) was classified as E1 type, 15
out of 31 (48.4%) were classified as E2 type, 12 out of 31
(38.7%) were classified as E3 type, and finally 3 out of 31
(9.7%) were classified as E4 type. According to MIRS disease
classification, 3 out of 31 (8.6%) were at the first stage of
disease, 13 out of 31 (41.9%) were at the second disease stage,
11 out of 31 (35.4%) were at the third stage, and 4 out of
31 (12.9%) were at the fourth stage. CTG triplet expansion
was negatively associated with years of formal education (𝑟 =
−0.62, 𝑝 = 0.002) and age at disease onset (𝑟 = −0.72, 𝑝 <
0.001). No significant correlationwas found between patients’
MIRS and MMSE scores.
All patients with DM1 reported a normal MMSE score
(range 26–30), though significantly lower thanHS. Exploring
specific cognitive domains (Table 3), DM1 patients performed
significantly worse than controls on a visuospatial task only
(Raven’s Coloured Progressive Matrices; F
1,55
= 16.1, 𝑝 <
0.001).
3.2. Resting-State fMRI
3.2.1. Network-Based Analysis. NBS analysis showed a sig-
nificant reduction of connectivity in patients with DM1
compared to HS in a large brain network formed by 51
different nodes and 83 edges (Figure 1, grey, blue, and
greennodes together). Conversely, no significant reduction in
connectivity was found in HS compared to DM1 patients. To
isolate a more restricted pattern of disconnection (i.e., core of
the dysfunctional network), we applied an extra Bonferroni’s
correction for multiple comparisons [𝛼 = 0.05/number of
participants (𝑁 = 57),𝑝 = 0.0008].This𝑝 value corresponds,
in Student’s 𝑇 distribution table, to 𝑡-values ≥ 3.24, with
55 degrees of freedom (i.e, dof = 𝑁 − 2, where 𝑁 is
the number of participants). The core of the dysfunctional
network included therefore pairs of nodes whose statistical
threshold corresponded to 𝑡-values ≥ 3.24, resulting in 37
nodes and 47 edges (Figure 1, blue and green nodes, and
Table 4). Within this “core” dysfunctional network, the mean
number of connections was 3.8 with a standard deviation
of 2.5. According to Materials and Methods, we defined as
“hubs” all nodes with at least 7 inter-Nodal connections.
Upon comparing DM1 patients to controls, dysfunctional
“hubs” were located in the bilateral anterior cingulum (show-
ing connectionswith 19 other brain regions), the orbitofrontal
cortex (showing connections with 14 other brain regions),
and the right parahippocampal gyrus (showing connections
with 7 other regions). Those nodes, surviving Bonferroni’s
correction but whose number of inter-Nodal connectivity
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R R
Entire dysfunctional network
Hubs
Peripheral nodes
Figure 1: Reduced connectivity ofDM1 brains obtained by network-
based analysis. Widespread pattern of functional brain disconnec-
tion in patients with DM1 compared to healthy subjects (grey, blue,
and green nodes). When Bonferroni’s correction was applied to
identify the most critical nodes of this dysfunctional network, two
populations were identified, the “hubs” (blue) and the peripheral
nodes (green). “Hubs,” characterized by the largest number of
connections, were located in the anterior cingulum and in the
orbitofrontal cortex bilaterally and in the right parahippocampal
gyrus. Peripheral nodes (green), characterized by a smaller number
of connections, were mainly located in the prefrontal, temporal, and
parietal cortices and in the cerebellum. In the picture, node’s size is
proportional to the number of its connections. The brain network
was visualized using the BrainNet Viewer (https://www.nitrc.org/
projects/bnv/) [21]. See text for further details. R = Right.
was lower than 7, were defined as peripheral nodes (Figure 1,
green nodes). In the comparison between DM1 patients
and controls, the peripheral nodes showing a significant
reduction of connectivity included the prefrontal, temporal,
parietal, and cerebellar regions.
In both groups, patients and controls, the normality of
distribution of the extent of network’s connectivity measure
was not satisfied (in DM1:𝑊 = 0.75, 𝑝 < 0.001; in HS:𝑊 =
0.63, 𝑝 < 0.001). With respect to DM1 patients, for whom
correlations were investigated between connectivity and cog-
nitive performance, this extent of network’s connectivity was
positively associated with patients’ scores at Raven’s Coloured
Progressive Matrices (𝑅 = 0.61, 𝑝 = 0.001).
3.2.2. Graph Theory Analysis
Global Measures of Connectivity. DM1 patients and controls
did not differ in any considered AUC global measure. In both
groups, patients and controls, the normality of distribution
of the global connectivity measures was not satisfied (data
not shown). In the DM1 group, we found significant positive
correlations between MIRS scores and Imv-NC (𝑅 = 0.48;
𝑝 = 0.014) and Imv-SWN (𝑅 = 0.52; 𝑝 = 0.008) and
a negative correlation between MIRS scores and the Imv-A
(𝑅 = −0.46; 𝑝 = 0.019).
Local Measures of Connectivity. Upon considering the Nodal
degree (Figure 2(a), Supplementary Table, in Supplementary
Material available online at http://dx.doi.org/10.1155/2016/
2696085), DM1 patients showed a significant reduction in
Table 4: Between-groups difference of functional connectivity into
pairwise brain regions.
Pairwise brain regions 𝑡-values∗
R superior frontal gyrus (orbital part)↔ R middle
frontal gyrus 3.67
L olfactory cortex↔ L orbitofrontal gyrus 3.85
L orbitofrontal gyrus↔ L rectus gyrus 4.70
L orbitofrontal gyrus↔ R rectus gyrus 4.82
L superior frontal gyrus (orbital part)↔ L cingulum
(anterior part) 4.17
L olfactory cortex↔ L cingulum (anterior part) 4.30
R olfactory cortex↔ L cingulum (anterior part) 3.73
L rectus gyrus↔ L cingulum (anterior part) 4.43
R rectus gyrus↔ L cingulum (anterior part) 4.37
L superior frontal gyrus (orbital part)↔ R cingulum
(anterior part) 3.84
R superior frontal gyrus (orbital part)↔ R cingulum
(anterior part) 3.63
L olfactory cortex↔ R cingulum (anterior part) 3.81
R rectus gyrus↔ R cingulum (anterior part) 3.92
R orbitofrontal gyrus↔ L parahippocampal gyrus 3.71
L orbitofrontal gyrus↔ R parahippocampal gyrus 3.68
R orbitofrontal gyrus↔ R parahippocampal gyrus 4.22
R olfactory cortex↔ L amygdala 4.70
L orbitofrontal gyrus↔ R amygdala 3.85
R orbitofrontal gyrus↔ R amygdala 3.86
R amygdala↔ L occipital gyrus 3.53
L superior frontal gyrus↔ L caudate 3.68
R superior frontal gyrus↔ L caudate 3.49
R rectus gyrus↔ L caudate 3.72
L superior frontal gyrus (medial part)↔ L pallidum 3.64
R orbitofrontal gyrus↔ L pallidum 3.48
L superior frontal gyrus (medial part)↔ R pallidum 3.61
R superior frontal gyrus (medial part)↔ R pallidum 3.62
R parahippocampal gyrus↔ R middle temporal gyrus 3.53
R amygdala↔ R middle temporal gyrus 4.29
R superior frontal gyrus (medial part)↔ L temporal
pole 3.83
R orbitofrontal gyrus↔ L temporal pole 4.44
L orbitofrontal gyrus↔ L inferior temporal gyrus 3.60
L inferior parietal gyrus↔ L inferior temporal gyrus 3.51
R orbitofrontal gyrus↔ R inferior temporal gyrus 3.59
R orbitofrontal gyrus↔ L cerebellum (Crus1) 3.84
R orbitofrontal gyrus↔ L cerebellum (Crus2) 4.65
R inferior frontal gyrus↔ L cerebellum (Crus2) 3.66
L cingulum (posterior part)↔ L cerebellum (Lobule 9) 4.40
R cingulum (posterior part)↔ L cerebellum (Lobule 9) 4.34
R precuneus R ↔ L cerebellum (Lobule 9) 3.55
L cingulum (anterior part)↔ L cerebellum (Lobule 9) 4.12
R cingulum (anterior part)↔ R cerebellum (Lobule 9) 3.66
L cingulum (posterior part)↔ R cerebellum (Lobule 9) 4.32
R cingulum (posterior part)↔ R cerebellum (Lobule 9) 3.53
L cingulum (anterior part)↔ vermis 3.52
R cingulum (anterior part)↔ vermis 3.47
L cingulum (posterior part)↔ vermis 3.81
R cingulum (posterior part)↔ vermis 3.58
∗Two-sample 𝑡-test with 55 degrees of freedom; 𝑡-values are reported. R =
right; L = left; and↔ = bidirectional connections.
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Nodal efficiency
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Figure 2: Abnormal topological properties of DM1 brains obtained by the graph theory analysis. Patients with DM1 compared to healthy
subjects showed both decreased (blue nodes) and increased (red nodes) functional connectivity in centrality measures. Upon considering the
Nodal degree (a) and Betweenness centrality (b) DM1 patients showed two distinct patterns, one located more anteriorly characterized by
decreased connectivity (blue nodes) and onemore posterior characterized by increased connectivity (red nodes).The formermainly involved
the superior frontal and orbitofrontal gyri bilaterally. The latter involved the supplementary motor area and the cerebellum. Nodal efficiency
(c) was reduced in the right superior frontal gyrus, in the right orbitofrontal gyrus and in the left angular gyrus. The brain network was
visualized using the BrainNet Viewer (https://www.nitrc.org/projects/bnv/) [21]. See text for further details. R = Right.
the superior frontal and in the orbitofrontal gyrus bilaterally.
Conversely, this samemeasure was increased inDM1 patients
compared to controls in the supplementary motor area,
bilaterally, and in the cerebellum.
Upon considering Betweenness centrality (Figure 2(b),
Supplementary Table), DM1 patients revealed reduced con-
nectivity compared to controls in the right superior frontal
gyrus, in the right inferior parietal gyrus, and in the right
putamen. In contrast, DM1 patients showed a significant
increase of connectivity in the right paracentral lobule, in the
right CRUS-I, and in the right Lobule 10 of the cerebellum.
Moreover, upon considering Nodal efficiency (Fig-
ure 2(c), Supplementary Table), DM1 patients revealed
reduced connectivity compared to controls in the right
superior frontal gyrus, in the right orbitofrontal cortex, and
in the left angular gyrus.
Finally, we found a significant negative correlation
between the Nodal degree (Imv-ND) of right CRUS-1 and the
patients’ CTG triplet expansions (𝑅 = −0.54, 𝑝 = 0.003).
4. Discussion
Here, we provide the first evidence for widespread abnormal-
ities in functional brain topological properties of DM1 brains.
This fits with previous evidence of widespread structural
alterations in DM1 patients, which are dominated by white
matter involvement [7–11].
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The majority of our patients had an adult or childhood
disease onset, and their muscular impairments’ severity was
mild to moderate. Consistent with previous studies [6, 7,
10], there was no significant association between patients’
CTG triplet expansion and MIRS scores, while a negative
association was found between CTG triplet expansion and
patients’ age at disease onset. This indicates that a more
severe genetic load associates with an earlier clinical onset,
as supported by a previous study by our own group [7].
On the other hand, it is known that, in other neurological
conditions, brain function does not linearly respond to the
accumulation of structural abnormalities, with a significant
modulation determined by environmental factors. In this
view, topological brain characteristics (i.e., measures of net-
works’ integrity and efficiency) might reflect better than
structural information the global modifications occurring to
DM1 brains.
We first performedNBS analysis, which revealed reduced
connectivity in DM1 patients within a widespread brain
network involving several nodes and edges, with the anterior
cingulate and the orbitofrontal cortices as core regions.These
regions are wired with several other nodes of the association
cortex, thus playing the role of “hubs.” It is interesting to
observe that although our DM1 patients performed within
the range of normality in most cognitive tests, they reported
poor scores at Raven’s Coloured Progressive Matrices. This
test assesses visuospatial reasoning, which is also regarded as
a component of general intelligence [39], andmainly engages
the orbitofrontal and parietal cortices [40]. Consistently, our
DM1 patients’ performance at Raven’s Coloured Progressive
Matrices test correlated with their extent of brain connec-
tivity. Taken altogether, these results indicate that abnormal
brain connectivity explains, at least partially, the patients’
deficits in reasoning.
Upon considering graph theoretical measures, DM1
patients did not reveal significant differences in global topo-
logical indices with respect to controls. Changes to global
measures typically reflect the presence of considerable brain
disorganization such as that observed in patients with severe
dementia [41]. The lack of significant reductions in global
segregation/integration measures in DM1 patients [41] is
therefore consistent with their relative preservation of general
cognitive efficiency. Nevertheless, some global measures of
connectivity (i.e., Assortativity, Normalized Clustering Coef-
ficient, and Small-Worldness) were associated with patients’
MIRS scores. The MIRS score returns a global measure of
disability in DM1 patients. It is based on the assessment
of progression of muscular impairment and, in principle, it
should reflect also some contribution of CNS involvement.
Indeed, it was previously shown that MIRS scores correlate
with the extension of white matter damage in DM1 patients
[7, 10]. Among global measures of connectivity, Assortativity
[19], which was negatively associated with our DM1 patients’
MIRS scores, has been previously regarded either as a mea-
sure of network vulnerability to pathological insults [42] or as
an index of brain tissue resilience. Additionally, Normalized
Clustering Coefficient and Small-Worldness, which were
positively associated with our patients’ MIRS scores, are con-
sidered as measures of network segregation and integration,
respectively. Taken altogether, higher network segregation
in the absence of a sufficient integration might reflect the
presence of dysfunctional communication between nodes
[20]. Considering this strict association between measures
of global brain connectivity and patients’ MIRS scores,
we believe they might be useful biomarkers for patients’
monitoring in clinical routine and trials.
Upon considering the local measures of brain connectiv-
ity, we found two distinct patterns in DM1 patients, namely,
a more anterior decrease and a more posterior increase of
connectivity. With respect to the anterior pattern, consistent
with the findings obtained by NBS analysis, DM1 patients
showed decreased connectivity in prefrontal (orbitofrontal
and superior frontal gyrus) and parietal (inferior parietal
and angular gyrus) regions. As mentioned above, these brain
regions are implicated in higher-level functions and may
account for patients’ cognitive and behavioural symptoms
[6, 7]. Consistently, a selective pattern of topological brain
alterations, including Nodal degree, Betweenness centrality,
and Nodal efficiency, was found in a selection of the nodes
belonging to this network. This indicates that some of these
nodes, which are the most “central” for an efficient transfer of
information, are affected. The reduction of Nodal efficiency
and Betweenness centrality that we found in patients’ angular
gyrus and inferior parietal gyrus, respectively, is only in
apparent contrast with the increase of functional connectivity
that we previously observed in a critical node of patients’
default mode network [6]. These brain regions are located
in neighbour but different brain areas, and these different
findings seem to be complementary to each other rather than
in contrast. Functional connectivity estimated by indepen-
dent component analysis [6] returns ameasure of segregation
similarly to that expressed by Nodal degree and Clustering
Coefficient as obtained by the graph theory. Conversely,
Nodal efficiency and Betweenness centrality (found to be
reduced here in DM1 patients) are regarded as measures
of integration [43]. In this view, as previously suggested by
van den Heuvel and Sporns [43], segregation and integration
measures produce complementary information, and our
previous and current findings are likely to detect different
aspects of the pathophysiological processes occurring toDM1
brains.
With respect to the posterior pattern, DM1 patients
showed increased connectivity in the supplementary motor
area (SMA) and in the right cerebellum (CRUS-1 and lobule
10). Similar abnormalities have also been observed in patients
with autism spectrum disorders (ASD) [44–46]. In this case,
the atypical pattern of increased connectivity between the
cerebellum and the sensorimotor areas was interpreted as a
possible substrate for the repetitive stereotyped behaviours
observed in autism [44]. Interestingly, autism-like traits have
also been previously reported in patients with congenital
DM1 [47]. Moreover, in the current work, we also found
a significant association between patients’ genetic load and
their Nodal degree connectivity in CRUS-I. The SMA, the
CRUS-1, and cerebellar lobule 10 are all regions implicated in
“internally generated” planning of movements, in the plan-
ning of sequences of movements, and in motor coordination
[48, 49].We believe that the severity of abnormal connectivity
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within this set of regions might be relevant for the clinical
interpretation of motor impairment in patients with DM1,
which can differ across individuals. Motor impairment in
DM1 is indeed predominantly due to muscular weakness.
However, a recent fMRI study reported an association
between myotonia and SMA activation in patients with DM1
[50], thus suggesting CNS contribution to patients’ motor
deficits [50]. In this view, we speculate that our findings
of abnormally high connectivity within the motor network
of DM1 patients might represent a compensatory, albeit
nonefficient or maladaptive, mechanism of brain plasticity
to contrast muscular impairment. This might be of clinical
interest for tailored neurorehabilitation programs in DM1.
In conclusion, the current study describes, for the first
time, the topological properties of brain functional net-
works in patients with DM1. Though preliminary, our data
contribute to clarifying some relevant pathophysiological
aspects of DM1, with a focus on both motor and nonmotor
symptoms. Not only is this of speculative interest but it
introduces a new potential tool for patients’ assessment and
monitoring. Finally, this work opens an important ques-
tion on the possibility of implementing novel therapeutic
approaches in clinical settings by using, for instance, the
transcranial magnetic stimulation (TMS), or the transcranial
direct current stimulation (TDCS). These techniques that
exploit the unique plasticity of the human brain have already
proven their usefulness inmodulating brain connectivity and
in improving the clinical outcome in various neurological
patients [51–53].
Competing Interests
None of the Authors has any conflict of interests to disclose.
Acknowledgments
TheNeuroimaging Laboratory is in part supported by grants
obtained by the Italian Ministry of Health.
References
[1] G. Meola and R. Cardani, “Myotonic dystrophies: an update on
clinical aspects, genetic, pathology, and molecular pathomech-
anisms,” Biochimica et Biophysica Acta (BBA)—Molecular Basis
of Disease, vol. 1852, no. 4, pp. 594–606, 2015.
[2] J. D. Brook, M. E. McCurrach, H. G. Harley et al., “Molecular
basis of myotonic dystrophy: expansion of a trinucleotide
(CTG) repeat at the 3󸀠 end of a transcript encoding a protein
kinase family member,” Cell, vol. 68, pp. 799–808, 1992.
[3] G. Meola, V. Sansone, D. Perani et al., “Executive dysfunction
and avoidant personality trait in myotonic dystrophy type 1
(DM-1) and in proximal myotonic myopathy (PROMM/DM-
2),” Neuromuscular Disorders, vol. 13, no. 10, pp. 813–821, 2003.
[4] A. Modoni, G. Silvestri, M. G. Vita, D. Quaranta, P. A. Tonali,
and C. Marra, “Cognitive impairment in myotonic dystrophy
type 1 (DM1): a longitudinal follow-up study,” Journal of Neu-
rology, vol. 255, no. 11, pp. 1737–1742, 2008.
[5] M. Douniol, A. Jacquette, D. Cohen et al., “Psychiatric and
cognitive phenotype of childhood myotonic dystrophy type 1,”
DevelopmentalMedicine and Child Neurology, vol. 54, no. 10, pp.
905–911, 2012.
[6] L. Serra, G. Silvestri, A. Petrucci et al., “Abnormal functional
brain connectivity and personality traits in myotonic dystrophy
type 1,”The JAMA Neurology, vol. 71, no. 5, pp. 603–611, 2014.
[7] L. Serra, A. Petrucci, B. Spano` et al., “How genetics affects
the brain to produce higher-level dysfunctions in myotonic
dystrophy type 1,” Functional Neurology, vol. 30, no. 1, pp. 21–
31, 2015.
[8] A. Di Costanzo, F. Di Salle, L. Santoro, V. Bonavita, and G.
Tedeschi, “Brain MRI features of congenital- and adult-form
myotonic dystrophy type 1: case-control study,” Neuromuscular
Disorders, vol. 12, no. 5, pp. 476–483, 2002.
[9] A. Di Costanzo, F. Di Salle, L. Santoro, A. Tessitore, V. Bonavita,
and G. Tedeschi, “Pattern and significance of white matter
abnormalities in myotonic dystrophy type 1: an MRI study,”
Journal of Neurology, vol. 249, no. 9, pp. 1175–1182, 2002.
[10] M. Minnerop, B. Weber, J. C. Schoene-Bake et al., “The brain in
myotonic dystrophy 1 and 2: evidence for a predominant white
matter disease,” Brain, vol. 134, part 12, pp. 3530–3546, 2011.
[11] J. R.Wozniak, B.A.Mueller, E. E.Ward,K.O. Lim, and J.W.Day,
“White matter abnormalities and neurocognitive correlates in
children and adolescents with myotonic dystrophy type 1: a
diffusion tensor imaging study,” Neuromuscular Disorders, vol.
21, no. 2, pp. 89–96, 2011.
[12] B. Echenne and G. Bassez, “Congenital and infantile myotonic
dystrophy,” Handbook of Clinical Neurology, vol. 113, pp. 1387–
1393, 2013.
[13] G. Meola and V. Sansone, “Cerebral involvement in myotonic
dystrophies,”Muscle andNerve, vol. 36, no. 3, pp. 294–306, 2007.
[14] T. Gili, M. Cercignani, L. Serra et al., “Regional brain atrophy
and functional disconnection across Alzheimer’s disease evolu-
tion,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 82,
no. 1, pp. 58–66, 2011.
[15] W.Koch, S. Teipel, S.Mueller et al., “Diagnostic power of default
mode network resting state fMRI in the detection ofAlzheimer’s
disease,”Neurobiology of Aging, vol. 33, no. 3, pp. 466–478, 2012.
[16] M. P. van den Heuvel and H. E. Hulshoff Pol, “Exploring
the brain network: a review on resting-state fMRI functional
connectivity,” European Neuropsychopharmacology, vol. 20, no.
8, pp. 519–534, 2010.
[17] M. E. Raichle and A. Z. Snyder, “A default mode of brain
function: a brief history of an evolving idea,” NeuroImage, vol.
37, no. 4, pp. 1083–1090, 2007.
[18] R. L. Buckner, J. R. Andrews-Hanna, and D. L. Schacter, “The
brain’s default network: anatomy, function, and relevance to
disease,” Annals of the New York Academy of Sciences, vol. 1124,
pp. 1–38, 2008.
[19] M. Rubinov and O. Sporns, “Complex network measures of
brain connectivity: uses and interpretations,” NeuroImage, vol.
52, no. 3, pp. 1059–1069, 2010.
[20] E. Bullmore and O. Sporns, “Complex brain networks: graph
theoretical analysis of structural and functional systems,”
Nature Reviews Neuroscience, vol. 10, pp. 186–198, 2009.
[21] M. Xia, J. Wang, and Y. He, “BrainNet Viewer: a network
visualization tool for human brain connectomics,” PLoS ONE,
vol. 8, no. 7, Article ID e68910, 2013.
[22] International Myotonic Dystrophy Consortium (IDMC), “New
nomenclature andDNA testing guidelines for myotonic dystro-
phy type 1 (DM1),”Neurology, vol. 54, no. 6, pp. 1218–1221, 2000.
10 Neural Plasticity
[23] D. Bu¨sch, N. Hagemann, andN. Bender, “The dimensionality of
the edinburgh handedness inventory: an analysis with models
of the item response theory,” Laterality, vol. 15, no. 6, pp. 610–
628, 2010.
[24] M. F. Folstein, S. E. Folstein, and P. R. McHugh, “‘Mini-mental
state’. A practical method for grading the cognitive state of
patients for the clinician,” Journal of Psychiatric Research, vol.
12, no. 3, pp. 189–198, 1975.
[25] G. A. Carlesimo, C. Caltagirone, and G. Gainotti, “The Mental
Deterioration Battery: normative data, diagnostic reliability and
qualitative analyses of cognitive impairment.The Group for the
Standardization of the Mental Deterioration Battery,” European
Neurology, vol. 36, no. 6, pp. 378–384, 1996.
[26] A. Orsini, D. Grossi, E. Capitani, M. Laiacona, C. Papagno,
and G. Vallar, “Verbal and spatial immediate memory span:
normative data from 1355 adults and 1112 children,” The Italian
Journal of Neurological Science, vol. 8, pp. 539–548, 1987.
[27] G. Miceli, A. Laudanna, C. Burani, and R. Capasso, Batteria per
l’Analisi dei Deficit Afasici, Berdata Ed, Milano, Italy, 1991.
[28] P. Caffarra, G. Vezzadini, F. Dieci, A. Zonato, and A. Venneri,
“Una versione abbreviata del test di Stroop: dati normativi nella
popolazione italiana,” Nuova Rivista di Neurologia, vol. 12, pp.
111–115, 2012.
[29] J. Mathieu, H. Boivin, D. Meunier, M. Gaudreault, and P. Be´gin,
“Assessment of a disease-specific muscular impairment rating
scale in myotonic dystrophy,”Neurology, vol. 56, no. 3, pp. 336–
340, 2001.
[30] A. Zalesky, A. Fornito, and E. T. Bullmore, “Network-based
statistic: identifying differences in brain networks,”NeuroImage,
vol. 53, no. 4, pp. 1197–1207, 2010.
[31] T. Itahashi, T. Yamada, H. Watanabe et al., “Altered network
topologies and hub organization in adults with autism: a
resting-state fMRI study,” PLoS ONE, vol. 9, no. 4, Article ID
e94115, 2014.
[32] B. C.M. vanWijk, C. J. Stam, and A. Daffertshofer, “Comparing
brain networks of different size and connectivity density using
graph theory,” PLoS ONE, vol. 5, no. 10, Article ID e13701, 2010.
[33] Z. Liu, Y. Zhang, H. Yan et al., “Altered topological pat-
terns of brain networks in mild cognitive impairment and
Alzheimer’s disease: a resting-state fmri study,” Psychiatry
Research—Neuroimaging, vol. 202, no. 2, pp. 118–125, 2012.
[34] M. A. Rocca, P. Valsasina, A. Meani, A. Falini, G. Comi, and M.
Filippi, “Impaired functional integration in multiple sclerosis: a
graph theory study,” Brain Structure and Function, vol. 221, no.
1, pp. 115–131, 2016.
[35] D. S. Bassett and E. Bullmore, “Small-world brain networks,”
The Neuroscientist, vol. 12, no. 6, pp. 512–523, 2006.
[36] A. J. Lerner, P. K. Ogrocki, and P. J. Thomas, “Network graph
analysis of category fluency testing,” Cognitive and Behavioral
Neurology, vol. 22, no. 1, pp. 45–52, 2009.
[37] Z. Yao, Y. Zhang, L. Lin et al., “Abnormal cortical networks
in mild cognitive impairment and Alzheimer’s disease,” PLoS
Computational Biology, vol. 6, no. 11, Article ID e1001006, 2010.
[38] M. Shim, D.-W. Kim, S.-H. Lee, and C.-H. Im, “Disruptions in
small-world cortical functional connectivity network during an
auditory oddball paradigm task in patients with schizophrenia,”
Schizophrenia Research, vol. 156, no. 2-3, pp. 197–203, 2014.
[39] G. Gainotti, P. D’Erme, G. Villa, and C. Caltagirone, “Focal
brain lesions and intelligence: a study with a new version of
Raven’s Colored Matrices,” Journal of Clinical and Experimental
Neuropsychology, vol. 8, no. 1, pp. 37–50, 1986.
[40] C.Wendelken, “Meta-analysis: how does posterior parietal cor-
tex contribute to reasoning?” Frontiers in Human Neuroscience,
vol. 8, article 1042, 2015.
[41] Z. Dai and Y. He, “Disrupted structural and functional brain
connectomes in mild cognitive impairment and Alzheimer’s
disease,” Neuroscience Bulletin, vol. 30, no. 2, pp. 217–232, 2014.
[42] M. E. J. Newman, “Assortative mixing in networks,” Physical
Review Letters, vol. 89, no. 20, Article ID 208701, 2002.
[43] M. P. van den Heuvel and O. Sporns, “An anatomical substrate
for integration among functional networks in human cortex,”
The Journal of Neuroscience, vol. 33, no. 36, pp. 14489–14500,
2013.
[44] A. M. D’Mello and C. J. Stoodley, “Cerebro-cerebellar circuits
in autism spectrum disorder,” Frontiers in Neuroscience, vol. 9,
article 408, 2015.
[45] S. K. Noonan, F. Haist, and R.-A. Mu¨ller, “Aberrant functional
connectivity in autism: evidence from low-frequency BOLD
signal fluctuations,” Brain Research, vol. 1262, pp. 48–63, 2009.
[46] A. J. Khan, A. Nair, C. L. Keown, M. C. Datko, A. J. Lincoln,
and R.-A. Mu¨ller, “Cerebro-cerebellar resting-state functional
connectivity in children and adolescents with autism spectrum
disorder,” Biological Psychiatry, vol. 78, no. 9, pp. 625–634, 2015.
[47] A.-B. Ekstro¨m, L. Hakena¨s-Plate, L. Samuelsson, M. Tulinius,
and E. Wentz, “Autism spectrum conditons in myotonic dys-
trophy type 1: a study on 57 individuals with congenital and
childhood forms,” American Journal of Medical Genetics, Part
B: Neuropsychiatric Genetics, vol. 147, no. 6, pp. 918–926, 2008.
[48] A. N. Carlsen, J. S. Eagles, and C. D. MacKinnon, “Transcranial
direct current stimulation over the supplementary motor area
modulates the preparatory activation level in the human motor
system,” Behavioural Brain Research, vol. 279, pp. 68–75, 2015.
[49] J. C. Houk and S. P. Wise, “Distributed modular architectures
linking basal ganglia, cerebellum, and cerebral cortex: their role
in planning and controlling action,” Cerebral Cortex, vol. 5, no.
2, pp. 95–110, 1995.
[50] A. Toth, E. Lovadi, S. Komoly et al., “Cortical involvement
during myotonia in myotonic dystrophy: an fMRI study,” Acta
Neurologica Scandinavica, vol. 132, no. 1, pp. 65–72, 2015.
[51] G. Koch, P. Porcacchia, V. Ponzo et al., “Effects of two weeks of
cerebellar theta burst stimulation in cervical dystonia patients,”
Brain Stimulation, vol. 7, no. 4, pp. 564–572, 2014.
[52] M. Kojovic, P. Kassavetis, M. Bologna et al., “Transcranial mag-
netic stimulation follow-up study in early Parkinson’s disease: a
decline in compensation with disease progression?”Movement
Disorders, vol. 30, no. 8, pp. 1098–1106, 2015.
[53] S. Cipollari, D. Veniero, C. Razzano, C. Caltagirone, G. Koch,
and P. Marangolo, “Combining TMS-EEG with transcranial
direct current stimulation language treatment in aphasia,”
Expert Review of Neurotherapeutics, vol. 15, no. 7, pp. 833–845,
2015.
Submit your manuscripts at
http://www.hindawi.com
Neurology 
Research International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Alzheimer’s Disease
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
International Journal of
Scientifica
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
Schizophrenia
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Neural Plasticity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
Autism
Sleep Disorders
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Neuroscience 
Journal
Epilepsy Research 
and Treatment
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Psychiatry 
Journal
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Depression Research 
and Treatment
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Brain Science
International Journal of
Stroke
Research and Treatment
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Neurodegenerative 
Diseases
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Cardiovascular Psychiatry 
and Neurology
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
